The 2 most recent market catalysts affecting $APGE, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Aug 12, 2026
Corporate Catalyst
Bearish
Impact 65
This Apogee Therapeutics Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
The filing details several analyst downgrades across various companies, including Apogee Therapeutics, On Holding AG, AtaiBeckley Inc, Legend Biotech Corporation, and Tencent Music…
Aug 10, 2026
Corporate Catalyst
Bearish
Impact 92
Apogee Therapeutics Q2 EPS $(1.14) Misses $(1.05) Estimate
Apogee Therapeutics (APGE) announced Q2 earnings per share of $(1.14), which fell short of the analyst consensus estimate of $(1.05) by 8.57%. This earnings miss is a significant c…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.